The Food Safety and Standards Authority of India (FSSAI) has imposed a ban on Everest brand asafoetida (hing) following reports of substandard quality and misbranding discovered during laboratory testing.
- FSSAI found significant discrepancies in Everest's asafoetida samples.
- Lab tests confirmed substandard quality and incorrect branding/labeling.
- The regulatory body has issued strict warnings and sales restrictions.
In a major blow to one of India's most prominent spice manufacturers, the Food Safety and Standards Authority of India (FSSAI) has banned the sale of Everest brand asafoetida. The decision follows rigorous laboratory testing that revealed the product failed to meet essential safety and quality benchmarks set by the national regulator.
The investigation was triggered after routine surveillance of packaged food products led to the collection of samples from various markets. The subsequent lab reports highlighted two critical issues: the physical and chemical composition of the asafoetida did not align with prescribed standards, and the branding on the packaging was found to be misleading to consumers. This dual failure of quality and transparency has prompted immediate regulatory action.
Why This Matters
BozokMedia analysis shows that this crackdown is a significant signal to the FMCG sector. When a market leader like Everest faces such stringent penalties, it underscores the growing scrutiny of food safety protocols in India and the critical need for brands to maintain uncompromising quality control measures.
The integrity of the spice supply chain is vital for public health; any deviation from labeling norms is a direct breach of consumer trust.
Beyond asafoetida, reports suggest that FSSAI is widening its investigation to include other spices and packaged food items from various manufacturers. The regulator has emphasized that misbranding—where the product's characteristics or ingredients are misrepresented—will be met with zero tolerance.
Historically, the Indian spice market has struggled with issues of adulteration and inconsistent quality. While large-scale manufacturers have traditionally been seen as safer options, this recent development serves as a reminder that even industry giants are subject to strict regulatory oversight and must continuously validate their production processes.
Frequently Asked Questions
1. Is the entire Everest spice range banned?
No, the current restriction specifically targets the asafoetida products identified in the failed lab tests.
2. What are the implications for consumers?
Consumers are advised to check for FSSAI certification and be cautious of products that show signs of inconsistent packaging or labeling.